A Multi-institutional Prospective Trial in the USA Confirms that the 4Kscore Accurately Identifies Men with High-grade Prostate Cancer

European Urology

Volumn 68, Issue 3, 2015, Pages 464-470

  Parekh, Dipen J ^a   Punnen, Sanoj ^a   Sjoberg, Daniel D ^b   Asroff, Scott W ^c   Bailen, James L ^d   Cochran, James S ^e   Concepcion, Raoul ^f   David, Richard D ^g   Deck, Kenneth B ^h   Dumbadze, Igor ⁱ   Gambla, Michael ^j   Grable, Michael S ^k   Henderson, Ralph J ^l   Karsh, Lawrence ^m   Krisch, Evan B ⁿ   Langford, Timothy D ^o   Lin, Daniel W ^p   McGee, Shawn M ^q   Munoz, John J ^r   Pieczonka, Christopher M ^s   Rieger Christ, Kimberley ^t   Saltzstein, Daniel R ^u   Scott, John W ^v   Shore, Neal D ^w   Sieber, Paul R ^x   Waldmann, Todd M ^y   Wolk, Fredrick N ^z   Zappala, Stephen M ^aa   more..

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c Delaware Valley Urology   (United States)

^d First Urology   (United States)

^e Urology Clinic of North Texas   (Mexico)

^f Urology Associates   (United States)

^g Skyline Urology   (United States)

^h Alliance Research Centers   (United States)

ⁱ Urology Group   (United States)

^j Central Ohio Urology Group   (United States)

^k Atlantic Urological Associates   (United States)

^l Regional Urology   (United States)

^m Urology Center of Colorado   (United States)

ⁿ Delaware Valley Urology LLC Voorhees   (United States)

^o Arkansas Urology   (United States)

^p UNIVERSITY OF WASHINGTON   (United States)

^q Adult and Pediatric Urology   (United States)

^r Manchester Water Works   (United States)

^s Associated Medical Professionals of NY PLLC   (United States)

^t LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^u Urology San Antonio   (United States)

^v Urology of Indiana   (United States)

^w Atlantic Urology Clinics   (United States)

^x Urological Associates of Lancaster   (United States)

^y Idaho Urologic Institute   (United States)

^z Skyline Urology   (United States)

^aa Andover Control   (United States)

more..

Author keywords

Biomarkers; Biopsy; Prostate cancer; Screening

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; KALLIKREIN; KALLIKREIN-RELATED PEPTIDASE 3, HUMAN; TISSUE KALLIKREIN;

4KSCORE; ADULT; AGED; ARTICLE; CALIBRATION; CANCER DIAGNOSIS; CANCER GRADING; CANCER STAGING; DELAYED DIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIGITAL RECTAL EXAMINATION; GLEASON SCORE; HEALTH CARE QUALITY; HUMAN; HUMAN TISSUE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MIDDLE AGED; MODEL; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; RISK ASSESSMENT; SCORING SYSTEM; UNITED STATES; AREA UNDER THE CURVE; BLOOD; CLINICAL TRIAL; COHORT ANALYSIS; LARGE CORE NEEDLE BIOPSY; PATHOLOGY; PROSTATIC NEOPLASMS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

AGED; AREA UNDER CURVE; BIOPSY, LARGE-CORE NEEDLE; COHORT STUDIES; HUMANS; KALLIKREINS; MALE; MIDDLE AGED; NEOPLASM GRADING; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TISSUE KALLIKREINS; UNITED STATES;

EID: 84940603595     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2014.10.021     Document Type: Article

References (19)

1. R. Siegel, J. Ma, Z. Zou, and A. Jemal Cancer statistics, 2014 CA Cancer J Clin 64 2014 9 29
2. V.A. Moyer U.S. Preventive Services Task Force Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement Ann Intern Med 157 2012 120 134
3. F.H. Schröder, J. Hugosson, M.J. Roobol, and et al. Screening and prostate-cancer mortality in a randomized European study N Engl J Med 360 2009 1320 1328
4. G.L. Andriole, E.D. Crawford, R.L. Grubb III, and et al. Mortality results from a randomized prostate-cancer screening trial N Engl J Med 360 2009 1310 1319
5. J. Hugosson, S. Carlsson, G. Aus, and et al. Mortality results from the Göteborg randomised population-based prostate-cancer screening trial Lancet Oncol 11 2010 725 732
6. S. Loeb, H.B. Carter, S.I. Berndt, W. Ricker, and E.M. Schaeffer Complications after prostate biopsy: data From SEER-Medicare J Urol 186 2011 1830 1834
7. R.K. Nam, R. Saskin, Y. Lee, and et al. Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy J Urol 189 2013 S12 S18
8. A.J. Vickers, A.M. Cronin, G. Aus, and et al. A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden BMC Med 6 2008 19
9. A. Benchikh, C. Savage, A. Cronin, and et al. A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France BMC Cancer 10 2010 635
10. A.J. Vickers, A.M. Cronin, M.J. Roobol, and et al. A four-kallikrein panel predicts prostate cancer in men with recent screening: data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam Clin Cancer Res 16 2010 3232 3239
11. A.J. Vickers, A.M. Cronin, G. Aus, and et al. Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate-specific antigen Cancer 116 2010 2612 2620
12. A. Vickers, A. Cronin, M. Roobol, and et al. Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replication J Clin Oncol 28 2010 2493 2498
13. A. Gupta, M.J. Roobol, C.J. Savage, and et al. A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer Screening in Rotterdam, Netherlands Br J Cancer 103 2010 708 714
14. J. Donovan, F. Hamdy, D. Neal, and et al. Prostate Testing for Cancer and Treatment (ProtecT) feasibility study Health Technol Assess 7 2003 1 88
15. A.J. Vickers, and E.B. Elkin Decision curve analysis: a novel method for evaluating prediction models Med Decis Making 26 2006 565 574
16. D.P. Ankerst, J. Hoefler, S. Bock, and et al. Prostate Cancer Prevention Trial Risk Calculator 2.0 for the prediction of low- vs high-grade prostate cancer Urology 83 2014 1362 1368
17. H.B. Carter, P.C. Albertsen, M.J. Barry, and et al. Early detection of prostate cancer: AUA guideline J Urol 190 2013 419 426
18. X. Zhu, P.C. Albertsen, G.L. Andriole, M.J. Roobol, F.H. Schröder, and A.J. Vickers Risk-based prostate cancer screening Eur Urol 61 2012 652 661
19. J.D. Voigt, S.M. Zappala, E.D. Vaughan, and A.J. Wein The kallikrein panel for prostate cancer screening: its economic impact Prostate 74 2013 250 259